ATE395600T1 - Verfahren zur diagnose von knochenmetastasen aus malignen tumoren - Google Patents
Verfahren zur diagnose von knochenmetastasen aus malignen tumorenInfo
- Publication number
- ATE395600T1 ATE395600T1 AT99938547T AT99938547T ATE395600T1 AT E395600 T1 ATE395600 T1 AT E395600T1 AT 99938547 T AT99938547 T AT 99938547T AT 99938547 T AT99938547 T AT 99938547T AT E395600 T1 ATE395600 T1 AT E395600T1
- Authority
- AT
- Austria
- Prior art keywords
- bone metastasis
- malignant tumors
- diagnosing bone
- marker
- reflects
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23614698 | 1998-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE395600T1 true ATE395600T1 (de) | 2008-05-15 |
Family
ID=16996446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99938547T ATE395600T1 (de) | 1998-08-21 | 1999-08-20 | Verfahren zur diagnose von knochenmetastasen aus malignen tumoren |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7632486B1 (de) |
| EP (1) | EP1107006B1 (de) |
| JP (1) | JP4420565B2 (de) |
| AT (1) | ATE395600T1 (de) |
| AU (1) | AU5302599A (de) |
| DE (1) | DE69938729D1 (de) |
| WO (1) | WO2000011480A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1882946T1 (sl) | 2003-12-23 | 2010-06-30 | Hoffmann La Roche | Postopek za ugotavljanje revmatoidnega artritisa z merjenjem anti CCP in interlevkina |
| EP2225559B8 (de) * | 2007-12-28 | 2016-12-21 | F. Hoffmann-La Roche AG | Beurteilung physiologischer bedingungen |
| US20140044736A1 (en) * | 2011-03-08 | 2014-02-13 | The Johns Hopkins University | Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases |
| MX2013012695A (es) | 2011-05-02 | 2014-03-27 | Exelixis Inc | Metodo para el tratamiento del cancer y el dolor por cancer de hueso. |
| CA2987372C (en) * | 2015-06-04 | 2024-02-20 | Nihon Medi-Physics Co., Ltd. | Diagnostic imaging agent for early bone metastasis from cancer |
| ES2967857T3 (es) * | 2018-08-03 | 2024-05-06 | Cytogen Inc | Composición para el diagnóstico de la metástasis ósea del cáncer y kit que la contiene |
| JP7080534B2 (ja) * | 2018-08-03 | 2022-06-06 | サイトジェン インコーポレーテッド | 癌の骨転移診断用組成物およびこれを含むキット |
| EP4317172A4 (de) * | 2021-03-24 | 2025-03-05 | Sekisui Medical Co., Ltd. | Immunologisches analyseverfahren für typ-i-kollagen-c-terminales tlopeptid |
| CN117316426B (zh) * | 2023-09-12 | 2026-01-20 | 上海市第六人民医院 | 基于骨转移特异性骨标志物的肿瘤骨转移预测系统及方法 |
| CN121393909B (zh) * | 2025-12-26 | 2026-03-24 | 海南省人民医院 | 基于骨转移特异性骨标志物的肿瘤骨转移预测系统及方法 |
-
1999
- 1999-08-20 EP EP99938547A patent/EP1107006B1/de not_active Expired - Lifetime
- 1999-08-20 JP JP2000566684A patent/JP4420565B2/ja not_active Expired - Fee Related
- 1999-08-20 US US09/763,370 patent/US7632486B1/en not_active Expired - Fee Related
- 1999-08-20 DE DE69938729T patent/DE69938729D1/de not_active Expired - Lifetime
- 1999-08-20 WO PCT/JP1999/004480 patent/WO2000011480A1/ja not_active Ceased
- 1999-08-20 AT AT99938547T patent/ATE395600T1/de not_active IP Right Cessation
- 1999-08-20 AU AU53025/99A patent/AU5302599A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7632486B1 (en) | 2009-12-15 |
| JP4420565B2 (ja) | 2010-02-24 |
| EP1107006A4 (de) | 2002-03-06 |
| DE69938729D1 (de) | 2008-06-26 |
| WO2000011480A1 (fr) | 2000-03-02 |
| EP1107006A1 (de) | 2001-06-13 |
| AU5302599A (en) | 2000-03-14 |
| EP1107006B1 (de) | 2008-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69738077D1 (de) | Tiermodelle für die menschliche prostatakrebsfortschreitung | |
| ATE294595T1 (de) | Radioaktive zusammensetzungen zur behandlung von prostatatumoren | |
| DE69730820D1 (de) | Polyazomacrocyclofluoromonoalkylphosphensäure, ihre komplexe zur verwendung als kontrastmittel | |
| DE69842094D1 (de) | Zusammensetzungen und Verfahren zur Behandlung primärer und metastatischer Erkrankungen mithilfe Arsentrioxid | |
| DE69918089D1 (de) | Btk inhibitoren und verfahren zur identifizierung und verwendung | |
| ATE345387T1 (de) | Verbindungen und verfahren für therapie und diagnose von lungenkrebs | |
| ATE469242T1 (de) | Zusammensetzungen und methoden zur identifizierung und zum targeting von krebszellen aus dem verdauungskanal | |
| EP1257287A4 (de) | Verbindungen und methoden zur frühdiagnose von eierstockkrebs | |
| ATE522623T1 (de) | Zusammensetzungen und verfahren zur behandlung und diagnose von lungentumoren | |
| EP0967015A3 (de) | Verwendung von Ferrocenylliganden zur katalytischen enantioselektiven Hydrierung | |
| ATE395600T1 (de) | Verfahren zur diagnose von knochenmetastasen aus malignen tumoren | |
| DE69927688D1 (de) | Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs | |
| AU3392901A (en) | Proteins | |
| ATE338142T1 (de) | Methoden zur diagnose und behandlung von herzkrankheiten | |
| DE60113968D1 (de) | Diagnose von brustkrebs unter verwendung von bcmp-7 als marker | |
| WO2003037257A3 (en) | Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 | |
| ATE435284T1 (de) | Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs | |
| ATE329597T1 (de) | Die verwendung von einer 4- pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren | |
| ATE337020T1 (de) | Fettsaure analoge zur diagnose von kranzarterie erkrankungen | |
| DE10296200D2 (de) | Verfahren zur Diagnose von Brustkrebserkrankungen, zugehörige Peptide und deren Verwendungen | |
| DE69931644D1 (de) | Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen | |
| ATE240352T1 (de) | Komplexverbindungen zur diagnose von gefässerkrankungen | |
| ATE546544T1 (de) | Verfahren zur diagnose und behandlung von lungenkrebs | |
| ATE423462T1 (de) | Verfahren zur diagnose von prostatakrebs | |
| WO2002034282A3 (en) | Mammary secreted protein 36 (msp36) for cancer treatment and diagnosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |